how can we continue the success of checkpoint inhibitors for bladder cancer treatment?
Published 6 years ago • 70 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:01
using checkpoint inhibitors at earlier stages of bladder cancer – the next step in immunotherapy?
-
1:28
immune checkpoint inhibitors and sitravatinib in bladder cancer
-
0:57
how do we select the urothelial carcinoma patients who will benefit from checkpoint inhibitors?
-
6:00
use of immune checkpoint inhibitors for bladder cancer
-
1:36
the synergistic antitumor activity of pan-pi3k inhibition and ici's in bladder cancer
-
1:42:32
how the universe will die? the end of everything. #sciencedocumentary
-
11:36
from failure to success – 4 steps to overcome failure & be successful | motivational video
-
6:12
how to find success in the process - not just the end goal
-
4:43
impact of immune checkpoint inhibitors on care of patients with advanced bladder cancer
-
2:40
‘it’s all about checkpoint inhibitors’ – rob jones on bladder cancer during asco 2017
-
1:56
immune checkpoint inhibitors for urothelial carcinoma: the current landscape
-
4:11
what's next for checkpoint inhibitors in metastatic urothelial bladder cancer?
-
18:43
lecture looking ahead - integrating immune checkpoint inhibitors into treatment paradigm for nmibc
-
30:23
lecture looking ahead - potential barriers to immune checkpoint inhibitors use in mibc
-
4:51
practical considerations with checkpoint inhibitors in bladder cancer
-
3:51
is pembrolizumab alone sufficient to treat bladder cancer?
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
10:44
earlier use of immune checkpoint inhibitors to adjuvant and non muscle invasive bladder cancer
-
3:27
improving anti-pd-1/pd-l1 therapy for localized bladder cancer
-
24:39
clinical case - immune check point inhibitor in the perioperative setting for mibc
-
1:29
will immune checkpoint inhibitors become the new standard of care for urothelial cancer?
-
1:51
dr. grivas on checkpoint inhibitors in localized bladder cancer